| 1 |
21516268 | Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib. | 2011 Apr 2 |
3 |
| 2 |
20499235 | Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with imatinib. | 2010 Nov |
2 |
| 3 |
19749982 | Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. | 2009 Sep |
3 |
| 4 |
18305564 | Successful peripheral blood stem cell mobilization with granulocyte colony-stimulating factor in a patient with chronic myeloid leukemia achieving a complete cytogenetic remission with dasatinib after failing imatinib. | 2008 Aug |
1 |
| 5 |
18751412 | Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV seminoma. | 2008 Jul-Aug |
2 |
| 6 |
16428509 | Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate. | 2006 Jan 15 |
6 |
| 7 |
27265480 | The effect of imatinib mesylate on the erythroid colony formation from patients with polycythemia vera in the presence of different cytokines. | 2006 Sep 5 |
1 |
| 8 |
15540243 | Granulocyte--colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia. | 2005 Jan 1 |
1 |
| 9 |
15124675 | Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells. | 2004 |
1 |
| 10 |
15197801 | Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia. | 2004 Jun 15 |
3 |
| 11 |
15553045 | [Imatinib mesylate plus G-CSF therapy for chronic myelogenous leukemia in the blastic crisis]. | 2004 Oct |
1 |
| 12 |
12604417 | Granulocyte colony-stimulating factor reverses cytopenia and may permit cytogenetic responses in patients with chronic myeloid leukemia treated with imatinib mesylate. | 2003 Feb |
1 |
| 13 |
12682643 | G-CSF for imatinib-induced neutropenia. | 2003 Apr |
1 |
| 14 |
12578590 | [Low Concentrations of STI571 Enhances beta1 Integrin Mediated Inhibitory Effect on Proliferation of Myeloid Progenitors in Ph(+)Chronic Myeloid Leukemia] | 2001 Sep |
1 |